Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
4.370
-0.030 (-0.68%)
Dec 20, 2024, 4:00 PM EST - Market closed
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $60.29 million as of December 20, 2024. Its market cap has decreased by -42.90% in one year.
Market Cap
60.29M
Enterprise Value
47.66M
1-Year Change
-42.90%
Ranking
Category
Stock Price
$4.37
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $60.29M, a decrease of -3.54%. That is a compound annual growth rate of -0.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 60.29M | -68.58% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeyondSpring | 62.47M |
| Milestone Scientific | 62.09M |
| Verrica Pharmaceuticals | 61.25M |
| Immix Biopharma | 61.07M |
| Vor Biopharma | 60.89M |
| Apyx Medical | 58.72M |
| Pheton Holdings | 58.57M |
| WORK Medical Technology Group LTD | 58.37M |